| 1 | Concern regarding missed non-ST-segment elevation myocardial infarctions when applying a single, pre-hospital cardiac troponin measurement | 2.2 | 1 | Citations (PDF) |
| 2 | Biomarkers for diagnosis and prognostication of acute aortic syndromes | 1.0 | 1 | Citations (PDF) |
| 3 | Machine Learning for Myocardial Infarction Compared With Guideline-Recommended Diagnostic Pathways | 19.4 | 8 | Citations (PDF) |
| 4 | How to use natriuretic peptides in non-cardiac surgery | 1.0 | 0 | Citations (PDF) |
| 5 | Combining anatomical and biochemical markers in the detection and risk stratification of coronary artery disease | 1.4 | 0 | Citations (PDF) |
| 6 | Association of preoperative beta-blocker use and cardiac complications after major noncardiac surgery: a prospective cohort study | 5.5 | 1 | Citations (PDF) |
| 7 | Prognostic Value and Determinants of High‐Sensitivity Cardiac Troponin T in Patients With a Systemic Right Ventricle: Insights From the SERVE Trial | 4.3 | 0 | Citations (PDF) |
| 8 | Enhancing the diagnosis of functionally relevant coronary artery disease with machine learning | 14.1 | 2 | Citations (PDF) |
| 9 | Glycoprotein IIb/IIIa inhibitors in acute myocardial infarction and angiographic microvascular obstruction: the REVERSE-FLOW trial | 2.2 | 4 | Citations (PDF) |
| 10 | Significance of an Early Repeat Troponin Measurement Upon Presentation to the Hospital for Acute Heart Failure | 4.3 | 0 | Citations (PDF) |
| 11 | Growth differentiation factor 15: a biomarker searching for an indication | 2.2 | 2 | Citations (PDF) |
| 12 | High-sensitivity Troponin I Predicts Major Cardiovascular Events after Non-Cardiac Surgery: A Vascular Events in Non-Cardiac Surgery Patients Cohort Evaluation (VISION) Substudy | 1.1 | 5 | Citations (PDF) |
| 13 | Association of accompanying dyspnoea with diagnosis and outcome of patients presenting with acute chest discomfort | 1.0 | 1 | Citations (PDF) |
| 14 | The roles of cardiac troponins before non-cardiac surgery | 2.2 | 2 | Citations (PDF) |
| 15 | High-sensitivity cardiac troponin in stable atherosclerotic vascular disease | 1.0 | 0 | Citations (PDF) |
| 16 | How to use cardiac troponin in non-cardiac surgery | 1.0 | 0 | Citations (PDF) |
| 17 | Troponin in early presenters to rule out myocardial infarction | 2.2 | 11 | Citations (PDF) |
| 18 | Bone Morphogenetic Protein 10—A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation | 4.3 | 14 | Citations (PDF) |
| 19 | Comparing the utility of clinical risk scores and integrated clinical judgement in patients with suspected acute coronary syndrome | 1.0 | 3 | Citations (PDF) |
| 20 | Cardiac troponin T and I: back to basics | 1.0 | 0 | Citations (PDF) |
| 21 | Prediction of perioperative myocardial infarction/injury in high-risk patients after noncardiac surgery | 1.0 | 6 | Citations (PDF) |
| 22 | Derivation and external validation of machine-learning models for risk stratification in chest pain with normal troponin | 1.0 | 2 | Citations (PDF) |
| 23 | Letter by Wussler et al Regarding Article, “Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?” | 19.4 | 0 | Citations (PDF) |
| 24 | D-Dimer in suspected pulmonary embolism | 1.0 | 1 | Citations (PDF) |
| 25 | Periprocedural myocardial infarction/injury after PCI | 1.0 | 0 | Citations (PDF) |
| 26 | 0/2 h-Algorithm for Rapid Triage of Suspected Myocardial Infarction Using a Novel High-Sensitivity Cardiac Troponin I Assay | 1.1 | 6 | Citations (PDF) |
| 27 | Long-term beta-blocker treatment in stable patients after myocardial infarction: a potential impact due to changes in the diagnosis of myocardial infarction? | 2.2 | 2 | Citations (PDF) |
| 28 | Factors associated with late presentation to the emergency department in patients complaining of chest pain | 2.0 | 1 | Citations (PDF) |
| 29 | Direct comparison of high-sensitivity cardiac troponin T and I in the early differentiation of type 1 vs. type 2 myocardial infarction | 1.0 | 12 | Citations (PDF) |
| 30 | European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis | 2.2 | 90 | Citations (PDF) |
| 31 | Biomarkers for Myocardial Infarction Type Discrimination—The Key Might Be in the Time Course of the Disease—Reply | 9.7 | 1 | Citations (PDF) |
| 32 | Correspondence on “Association between cardiologist evaluation and mortality in myocardial injury after non-cardiac surgery” by Park et alHeart, 2022, 108, 154-154 | 2.8 | 1 | Citations (PDF) |
| 33 | Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction | 10.5 | 51 | Citations (PDF) |
| 34 | Identification of myocardial injury using perioperative troponin surveillance in major noncardiac surgery and net benefit over the Revised Cardiac Risk Index | 5.5 | 26 | Citations (PDF) |
| 35 | Incidence, clinical presentation, management, and outcome of acute pericarditis and myopericarditis | 1.0 | 6 | Citations (PDF) |
| 36 | Acute Heart Failure in the 2021 ESC Heart Failure Guidelines: a scientific statement from the Association for Acute CardioVascular Care (ACVC) of the European Society of Cardiology | 1.0 | 35 | Citations (PDF) |
| 37 | Future application of point of care high-sensitivity cardiac troponin testing in the Emergency Department | 1.0 | 3 | Citations (PDF) |
| 38 | Adding stress biomarkers to high-sensitivity cardiac troponin for rapid non-ST-elevation myocardial infarction rule-out protocols | 1.0 | 9 | Citations (PDF) |
| 39 | How to implement novel diagnostic algorithms for non-ST-segment elevation myocardial infarction in the emergency department | 1.0 | 1 | Citations (PDF) |
| 40 | Biomarkers-in-Cardiology 8 RE-VISITED—Consistent Safety of Early Discharge with a Dual Marker Strategy Combining a Normal hs-cTnT with a Normal Copeptin in Low-to-Intermediate Risk Patients with Suspected Acute Coronary Syndrome—A Secondary Analysis of the Randomized Biomarkers-in-Cardiology 8 Trial | 4.8 | 3 | Citations (PDF) |
| 41 | Blood and imaging biomarkers in type 2 myocardial infarction | 1.0 | 1 | Citations (PDF) |
| 42 | A 0/1h-algorithm using cardiac myosin-binding protein C for early diagnosis of myocardial infarction | 1.0 | 7 | Citations (PDF) |
| 43 | Prevalence, Related Factors and Association of Left Bundle Branch Block With Prognosis in Patients With Acute Heart Failure: a Simultaneous Analysis in 3 Independent Cohorts | 1.3 | 5 | Citations (PDF) |
| 44 | Patient- and procedure-related factors in the pathophysiology of perioperative myocardial infarction/injury | 2.2 | 8 | Citations (PDF) |
| 45 | 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure | 8.2 | 1,238 | Citations (PDF) |
| 46 | Soluble urokinase plasminogen activator receptor and functionally relevant coronary artery disease: a prospective cohort study | 2.0 | 3 | Citations (PDF) |
| 47 | European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis | 5.6 | 33 | Citations (PDF) |
| 48 | How to deal with unexpected cardiac troponin results | 1.0 | 11 | Citations (PDF) |
| 49 | Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD) | 3.0 | 15 | Citations (PDF) |
| 50 | Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology | 8.2 | 37 | Citations (PDF) |
| 51 | Characteristics and Outcomes of Type 2 Myocardial Infarction | 9.7 | 16 | Citations (PDF) |
| 52 | Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study | 19.1 | 309 | Citations (PDF) |
| 53 | Cardiovascular imaging following perioperative myocardial infarction/injury | 3.7 | 0 | Citations (PDF) |
| 54 | Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T | 19.4 | 54 | Citations (PDF) |
| 55 | A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk | 13.1 | 43 | Citations (PDF) |
| 56 | Lower diagnostic accuracy of hs-cTnI in patients with prior coronary artery bypass grafting | 2.2 | 4 | Citations (PDF) |
| 57 | Decongestion, kidney injury and prognosis in patients with acute heart failure | 2.2 | 9 | Citations (PDF) |
| 58 | Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology | 2.2 | 22 | Citations (PDF) |
| 59 | OUP accepted manuscript | 1.0 | 2 | Citations (PDF) |
| 60 | Non‐invasive evaluation of new‐onset atrial fibrillation after cardiac surgery: a protocol for the BigMap study | 3.4 | 1 | Citations (PDF) |
| 61 | International Validation of the Canadian Syncope Risk Score | 10.5 | 13 | Citations (PDF) |
| 62 | Cardiac remodelling – Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology | 8.2 | 28 | Citations (PDF) |
| 63 | The origin and future of cardiac troponin testing | 1.0 | 4 | Citations (PDF) |
| 64 | The clinical approach to diagnosing peri-procedural myocardial infarction after percutaneous coronary interventions according to the fourth universal definition of myocardial infarction – from the study group on biomarkers of the European Society of Cardiology (ESC) Association for Acute CardioVascular Care (ACVC) | 2.0 | 3 | Citations (PDF) |
| 65 | Performance of the American Heart Association/American College of Cardiology/Heart Rhythm Society versus European Society of Cardiology guideline criteria for hospital admission of patients with syncope | 0.8 | 3 | Citations (PDF) |
| 66 | Perioperative myocardial injury and mortality after revision surgery for orthopaedic device-related infection | 3.8 | 2 | Citations (PDF) |
| 67 | Diurnal Variations in Natriuretic Peptide Levels: Clinical Implications for the Diagnosis of Acute Heart Failure | 4.8 | 5 | Citations (PDF) |
| 68 | Finding acute coronary syndrome with serial troponin testing for rapid assessment of cardiac ischemic symptoms (FAST-TRAC): a study protocol | 1.5 | 3 | Citations (PDF) |
| 69 | Screening the general population: a role for cardiac biomarkers? | 1.0 | 0 | Citations (PDF) |
| 70 | How is cardiac troponin released from cardiomyocytes? | 1.0 | 13 | Citations (PDF) |
| 71 | European Society of Cardiology quality indicators for the cardiovascular pre-operative assessment and management of patients considered for non-cardiac surgery. Developed in collaboration with the European Society of Anaesthesiology and Intensive Care | 4.0 | 4 | Citations (PDF) |
| 72 | Extending the no objective testing rules to patients triaged by the European Society of Cardiology 0/1-hour algorithms | 1.0 | 3 | Citations (PDF) |
| 73 | Cardiac biomarkers in the field of cardio-oncology | 1.0 | 1 | Citations (PDF) |
| 74 | Response by du Fay de Lavallaz et al to Letter Regarding Article, “Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T” | 19.4 | 1 | Citations (PDF) |
| 75 | The retirement of CKMB | 1.0 | 0 | Citations (PDF) |
| 76 | Use of vasodilators in patients with acute heart failure: contra | 1.0 | 1 | Citations (PDF) |
| 77 | Early kinetics of cardiac troponin in suspected acute myocardial infarction | 0.5 | 5 | Citations (PDF) |
| 78 | Frailty to predict unplanned hospitalization, stroke, bleeding, and death in atrial fibrillation | 4.0 | 37 | Citations (PDF) |
| 79 | Association between self-reported functional capacity and major adverse cardiac events in patients at elevated risk undergoing noncardiac surgery: a prospective diagnostic cohort study | 5.5 | 45 | Citations (PDF) |
| 80 | Early Rule-Out Strategies in the Emergency Department Utilizing High-Sensitivity Cardiac Troponin Assays | 1.1 | 14 | Citations (PDF) |
| 81 | Potential Utility of Cardiorenal Biomarkers for Prediction and Prognostication of Worsening Renal Function in Acute Heart Failure | 1.3 | 14 | Citations (PDF) |
| 82 | 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation | 2.2 | 3,440 | Citations (PDF) |
| 83 | 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease | 2.2 | 1,042 | Citations (PDF) |
| 84 | 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) | 2.2 | 6,821 | Citations (PDF) |
| 85 | Questions and answers on workup diagnosis and risk stratification: a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation | 2.2 | 13 | Citations (PDF) |
| 86 | ESC Study Group on Cardiac Biomarkers of the Association for Acute CardioVascular Care: A fond farewell at the retirement of CKMB | 2.2 | 23 | Citations (PDF) |
| 87 | Women who experience a myocardial infarction at a young age | 2.2 | 1 | Citations (PDF) |
| 88 | Development and Validation of a Simplified Probability Assessment Score Integrated With Age‐Adjusted
<scp>d</scp>
‐Dimer for Diagnosis of Acute Aortic Syndromes | 4.3 | 28 | Citations (PDF) |
| 89 | Cardiac myosin‐binding protein <scp>C</scp> in the diagnosis and risk stratification of acute heart failure | 8.2 | 9 | Citations (PDF) |
| 90 | Cardiovascular biomarkers in patients with COVID-19 | 1.0 | 42 | Citations (PDF) |
| 91 | Effect of COVID-19 on acute treatment of ST-segment elevation and Non-ST-segment elevation acute coronary syndrome in northwestern Switzerland | 0.8 | 7 | Citations (PDF) |
| 92 | Influence of renin‐angiotensin‐aldosterone system inhibitors on plasma levels of angiotensin‐converting enzyme 2 | 3.4 | 8 | Citations (PDF) |
| 93 | Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS). Comment on Br J Anaesth 2021; 126: 163–71 | 5.5 | 0 | Citations (PDF) |
| 94 | Synergistic Impact of Systolic Blood Pressure and Perfusion Status on Mortality in Acute Heart Failure | 4.8 | 19 | Citations (PDF) |
| 95 | Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy | 8.2 | 54 | Citations (PDF) |
| 96 | Incidence and outcomes of perioperative myocardial infarction/injury diagnosed by high-sensitivity cardiac troponin I | 3.0 | 23 | Citations (PDF) |
| 97 | Diagnostic Performance of the European Society of Cardiology 0/1-h Algorithms in Late Presenters | 2.6 | 6 | Citations (PDF) |
| 98 | The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC | 2.2 | 95 | Citations (PDF) |
| 99 | External Validation and Extension of a Clinical Score for the Discrimination of Type 2 Myocardial Infarction | 2.6 | 4 | Citations (PDF) |
| 100 | The role of cardiac testing with the 0/1-hour high-sensitivity cardiac troponin algorithm evaluating for acute myocardial infarction | 2.9 | 7 | Citations (PDF) |
| 101 | Decongestion discriminates risk for one‐year mortality in patients with improving renal function in acute heart failure | 8.2 | 20 | Citations (PDF) |
| 102 | The struggle towards a Universal Definition of Heart Failure—how to proceed? | 2.2 | 68 | Citations (PDF) |
| 103 | External validation of the clinical chemistry score | 1.8 | 5 | Citations (PDF) |
| 104 | External Validation of the No Objective Testing Rules in Acute Chest Pain | 4.3 | 2 | Citations (PDF) |
| 105 | Prognostic Utility of a Modified HEART Score When Different Troponin Cut Points Are Used | 0.2 | 2 | Citations (PDF) |
| 106 | Downstream Consequences of Implementing High-Sensitivity Cardiac Troponin | 2.6 | 4 | Citations (PDF) |
| 107 | Cardiovascular biomarkers in COVID-19 | 1.0 | 2 | Citations (PDF) |
| 108 | MO355ACUTE KIDNEY INJURY INCREASES THE RISK FOR SUBSEQUENT HEART FAILURE HOSPITALIZATIONS | 0.8 | 0 | Citations (PDF) |
| 109 | Relation of Decongestion and Time to Diuretics to Biomarker Changes and Outcomes in Acute Heart Failure | 1.9 | 9 | Citations (PDF) |
| 110 | Guía ESC 2020 sobre el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST | 1.1 | 20 | Citations (PDF) |
| 111 | Readmission following both cardiac and non‐cardiac acute dyspnoea is associated with a striking risk of death | 3.4 | 6 | Citations (PDF) |
| 112 | Cinética temprana de troponina en pacientes con sospecha de infarto agudo de miocardio | 1.1 | 3 | Citations (PDF) |
| 113 | Activity of the adrenomedullin system to personalise post-discharge diuretic treatment in acute heart failure | 3.0 | 8 | Citations (PDF) |
| 114 | The ‘Peptide for Life’ Initiative: a call for action to provide equal access to the use of natriuretic peptides in the diagnosis of acute heart failure across <scp>Europe</scp> | 8.2 | 14 | Citations (PDF) |
| 115 | Cardiovascular Biomarkers in the Early Discrimination of Type 2 Myocardial Infarction | 9.7 | 27 | Citations (PDF) |
| 116 | Effect of a strategy of comprehensive vasodilation versus usual care on health‐related quality of life among patients with acute heart failure | 3.4 | 6 | Citations (PDF) |
| 117 | Rapid diagnostic algorithms for non-ST-segment elevation myocardial infarction | 1.0 | 0 | Citations (PDF) |
| 118 | Prospective Validation of the ESC 0/1h-Algorithm Using High-Sensitivity Cardiac Troponin I | 1.9 | 6 | Citations (PDF) |
| 119 | 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure | 2.2 | 7,436 | Citations (PDF) |
| 120 | Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (<scp>HFA</scp>), European Society of Cardiology (<scp>ESC</scp>) | 8.2 | 92 | Citations (PDF) |
| 121 | Novel Criteria for the Observe-Zone of the ESC 0/1h-hs-cTnT Algorithm | 19.4 | 31 | Citations (PDF) |
| 122 | Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology | 8.2 | 28 | Citations (PDF) |
| 123 | Biomarker-driven prognostic model for risk prediction in heart failure: ready for Prime time? | 2.2 | 4 | Citations (PDF) |
| 124 | Biomarkers, Clinical Variables, and the CHA2DS2-VASc Score to Detect Silent Brain Infarcts in Atrial Fibrillation Patients | 5.1 | 3 | Citations (PDF) |
| 125 | Utility of Echocardiography in Patients With Suspected Acute Myocardial Infarction and Left Bundle‐Branch Block | 4.3 | 3 | Citations (PDF) |
| 126 | Performance of the ESC 0/2h-algorithm using high-sensitivity cardiac troponin I in the early diagnosis of myocardial infarction | 2.9 | 10 | Citations (PDF) |
| 127 | Adherence to the European Society of Cardiology/European Society of Anaesthesiology recommendations on preoperative cardiac testing and association with positive results and cardiac events: a cohort study | 5.5 | 7 | Citations (PDF) |
| 128 | Validation of the Novel European Society of Cardiology 0/2-hour Algorithm Using Hs-cTnT in the Early Diagnosis of Myocardial Infarction | 1.9 | 1 | Citations (PDF) |
| 129 | Development of an electrocardiogram-based risk calculator for a cardiac cause of syncopeHeart, 2021, 107, 1796-1804 | 2.8 | 8 | Citations (PDF) |
| 130 | The FAST-FURO study: effect of very early administration of intravenous furosemide in the prehospital setting to patients with acute heart failure attending the emergency department | 1.0 | 6 | Citations (PDF) |
| 131 | Association of Previous Myocardial Infarction and Time to Presentation With Suspected Acute Myocardial Infarction | 4.3 | 2 | Citations (PDF) |
| 132 | Cardiac myosin-binding protein C as a biomarker of acute myocardial infarction | 1.0 | 9 | Citations (PDF) |
| 133 | Biomarker-based risk scores in atrial fibrillation | 1.0 | 1 | Citations (PDF) |
| 134 | Incidence of major adverse cardiac events following non-cardiac surgery | 1.0 | 65 | Citations (PDF) |
| 135 | Influence of previous coronary artery bypass grafting in the difficulty of acute coronary syndrome diagnosis | 1.5 | 2 | Citations (PDF) |
| 136 | The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination | 1.5 | 16 | Citations (PDF) |
| 137 | Real-world experience of feasibility and efficacy of electrical muscle stimulation in elderly patients with acute heart failure: A randomized controlled study | 2.2 | 6 | Citations (PDF) |
| 138 | Postoperative Hypotension and Myocardial Injury: Comment | 3.3 | 1 | Citations (PDF) |
| 139 | Letter by Schaefer et al Regarding Article, “Diagnostic Performance of High-Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite US Cohort” | 19.4 | 0 | Citations (PDF) |
| 140 | Clinical presentation of patients with prior coronary artery bypass grafting and suspected acute myocardial infarction | 1.0 | 2 | Citations (PDF) |
| 141 | Biomarkers of coagulation and fibrinolysis in acute myocardial infarction: a joint position paper of the Association for Acute CardioVascular Care and the European Society of Cardiology Working Group on Thrombosis | 1.0 | 10 | Citations (PDF) |
| 142 | Effectiveness, Adherence, and Safety of Evolocumab in a Swiss Multicenter Prospective Observational Study | 3.4 | 11 | Citations (PDF) |
| 143 | Akuter Myokardinfarkt ohne ST-Hebung (NSTEMI): Wie Algorithmen die Diagnose beschleunigen 2021, , | | 1 | Citations (PDF) |
| 144 | The Study Group on Biomarkers of the ESC Association for Acute Cardiovascular Care | 1.0 | 1 | Citations (PDF) |
| 145 | Incremental value of high-frequency QRS analysis for diagnosis and prognosis in suspected exercise-induced myocardial ischaemia | 1.0 | 8 | Citations (PDF) |
| 146 | 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk | 2.2 | 5,743 | Citations (PDF) |
| 147 | 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC) | 2.2 | 782 | Citations (PDF) |
| 148 | 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD | 2.2 | 2,979 | Citations (PDF) |
| 149 | 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) | 2.2 | 2,922 | Citations (PDF) |
| 150 | It is B-type and not brain natriuretic peptide after all | 2.2 | 0 | Citations (PDF) |
| 151 | Evaluation of kidney function throughout the heart failure trajectory – a position statement from the Heart Failure Association of the European Society of Cardiology | 8.2 | 261 | Citations (PDF) |
| 152 | Short‐term prognostic implications of serum and urine neutrophil gelatinase‐associated lipocalin in acute heart failure: findings from the AKINESIS study | 8.2 | 20 | Citations (PDF) |
| 153 | Safely Ruling Out Myocardial Infarction Using a Single Cutoff Troponin Measurement | 2.6 | 0 | Citations (PDF) |
| 154 | Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (<i>de novo</i>) heart failure: a subgroup analysis of the TRANSITION study | 8.2 | 53 | Citations (PDF) |
| 155 | Performance of the ESC 0/1-h and 0/3-h Algorithm for the Rapid Identification of Myocardial Infarction Without ST-Elevation in Patients With Diabetes | 9.5 | 17 | Citations (PDF) |
| 156 | Etiology of Peri-Operative Myocardial Infarction/Injury After Noncardiac Surgery and Associated Outcome | 2.6 | 41 | Citations (PDF) |
| 157 | <scp>Heart Failure Association</scp> of the <scp>European Society of Cardiology</scp> update on sodium–glucose co‐transporter 2 inhibitors in heart failure | 8.2 | 69 | Citations (PDF) |
| 158 | Incidence, characteristics, determinants, and prognostic impact of recurrent syncope | 1.9 | 9 | Citations (PDF) |
| 159 | Long‐Term Results After Drug‐Eluting Versus Bare‐Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled Trial | 4.3 | 7 | Citations (PDF) |
| 160 | Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the <scp>Cardio‐Oncology Study Group</scp> of the <scp>Heart Failure Association</scp> and the <scp>Cardio‐Oncology Council of the European Society of Cardiology</scp> | 8.2 | 219 | Citations (PDF) |
| 161 | In Reply to Association of Procalcitonin Concentrations with Pathogenic Microorganisms | 1.1 | 1 | Citations (PDF) |
| 162 | Re: Myocardial Injury After Noncardiac Surgery: Incidence, Predictive Factors, and Outcome in High-Risk Patients Undergoing Thoracic Surgery: An Observational Study | 1.4 | 0 | Citations (PDF) |
| 163 | Letter by Schoepfer et al Regarding Article, “Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort” | 19.4 | 0 | Citations (PDF) |
| 164 | Definition of Type 2 Myocardial Infarction and its Impact on Prognosis | 2.6 | 0 | Citations (PDF) |
| 165 | Neutrophil Gelatinase-Associated Lipocalin Measured on Clinical Laboratory Platforms for the Prediction of Acute Kidney Injury and the Associated Need for Dialysis Therapy: A Systematic Review and Meta-analysis | 5.6 | 96 | Citations (PDF) |
| 166 | Rhabdomyolysis | 2.6 | 9 | Citations (PDF) |
| 167 | Effect of a Proposed Modification of the Type 1 and Type 2 Myocardial Infarction Definition on Incidence and Prognosis | 19.4 | 15 | Citations (PDF) |
| 168 | Using High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia in Symptomatic Patients | 10.5 | 21 | Citations (PDF) |
| 169 | High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia in Symptomatic Patients | 10.5 | 0 | Citations (PDF) |
| 170 | Risk stratification scores for patients with acute heart failure in the Emergency Department: A systematic review | 1.0 | 30 | Citations (PDF) |
| 171 | Plasma extracellular vesicle proteins are associated with stress-induced myocardial ischemia in women presenting with chest pain | 3.7 | 18 | Citations (PDF) |
| 172 | Reply to Shang & Feng et al. | 2.2 | 0 | Citations (PDF) |
| 173 | Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial | 2.2 | 42 | Citations (PDF) |
| 174 | Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction | 19.4 | 33 | Citations (PDF) |
| 175 | Application of the fourth universal definition of myocardial infarction in clinical practice | 2.0 | 2 | Citations (PDF) |
| 176 | External validation of an emergency department triage algorithm for chest pain patients | 1.0 | 1 | Citations (PDF) |
| 177 | Letter by Belkin et al Regarding Article, “Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction” | 19.4 | 0 | Citations (PDF) |
| 178 | Reader's Comment on “Relation of Low Triiodothyronine Syndrome Associated With Aging and Malnutrition to Adverse Outcome in Patients With Acute Heart Failure” | 1.9 | 1 | Citations (PDF) |
| 179 | Diagnostic and prognostic values of the QRS‐T angle in patients with suspected acute decompensated heart failure | 3.4 | 9 | Citations (PDF) |
| 180 | Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology | 8.2 | 323 | Citations (PDF) |
| 181 | Mortality and pathophysiology of acute kidney injury according to time of occurrence in acute heart failure | 3.4 | 5 | Citations (PDF) |
| 182 | High-Sensitivity Troponin-T and Cardiovascular Outcomes in the Community: Differences Between Women and Men | 2.6 | 10 | Citations (PDF) |
| 183 | Coronary Heart Disease and TMAO Concentrations | 2.6 | 8 | Citations (PDF) |
| 184 | Letter by Coscia et al Regarding Article, “High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction” | 19.4 | 2 | Citations (PDF) |
| 185 | Biomarkers for prediction of mortality in left-sided infective endocarditis | 2.2 | 15 | Citations (PDF) |
| 186 | The association of long-term outcome and biological sex in patients with acute heart failure from different geographic regions | 2.2 | 53 | Citations (PDF) |
| 187 | Early Diagnosis of Myocardial Infarction With Point-of-Care High-Sensitivity Cardiac Troponin I | 2.6 | 111 | Citations (PDF) |
| 188 | Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction | 4.9 | 0 | Citations (PDF) |
| 189 | Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology | 8.2 | 107 | Citations (PDF) |
| 190 | Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the <scp>H</scp>eart <scp>F</scp>ailure <scp>A</scp>ssociation (<scp>HFA</scp>), the <scp>E</scp>uropean <scp>A</scp>ssociation of <scp>C</scp>ardiovascular <scp>I</scp>maging (<scp>EACVI</scp>) and the <scp>Cardio‐Oncology C</scp>ouncil of the <scp>E</scp>uropean <scp>S</scp>ociety of <scp>C</scp>ardiology (<scp>ESC</scp>) | 8.2 | 263 | Citations (PDF) |
| 191 | Obesity paradox and perioperative myocardial infarction/injury in non-cardiac surgery | 3.0 | 16 | Citations (PDF) |
| 192 | High-sensitivity cardiac troponin assays for cardiovascular risk stratification in the general population | 2.2 | 96 | Citations (PDF) |
| 193 | Diagnostic and prognostic value of ST-segment deviation scores in suspected acute myocardial infarction | 1.0 | 3 | Citations (PDF) |
| 194 | Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology | 1.0 | 44 | Citations (PDF) |
| 195 | Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association | 1.0 | 107 | Citations (PDF) |
| 196 | Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high‐risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology | 8.2 | 63 | Citations (PDF) |
| 197 | High‐sensitivity cardiac troponin T 30 days all‐come mortality in patients with acute heart failure. A Propensity Score‐Matching Analysis Based on the EAHFE Registry. TROPICA4 Study | 3.2 | 5 | Citations (PDF) |
| 198 | Subcutaneous Selatogrel Inhibits Platelet Aggregation in Patients With Acute Myocardial Infarction | 2.6 | 60 | Citations (PDF) |
| 199 | Stress-delta B-type Natriuretic Peptide Levels as a Test for Inducible Myocardial Ischemia: A Systematic Review and Meta-Analysis | 0.6 | 1 | Citations (PDF) |
| 200 | Mortality prediction in acute heart failure: scores or biomarkers? | 1.5 | 13 | Citations (PDF) |
| 201 | Choir singing improves respiratory muscle strength and quality of life in patients with structural heart disease – HeartChoir: a randomised clinical trial | 1.5 | 4 | Citations (PDF) |
| 202 | Use of cardiac troponin in the early diagnosis of acute myocardial infarction | 0.6 | 7 | Citations (PDF) |
| 203 | Circadian, weekly, seasonal, and temperature-dependent patterns of syncope aetiology in patients at increased risk of cardiac syncope | 1.9 | 7 | Citations (PDF) |
| 204 | Copeptin to rule out myocardial infarction in Blacks versus Caucasians | 1.0 | 6 | Citations (PDF) |
| 205 | Machine Learning to Predict the Likelihood of Acute Myocardial Infarction | 19.4 | 153 | Citations (PDF) |
| 206 | Predicting Major Adverse Events in Patients With Acute Myocardial Infarction | 2.6 | 30 | Citations (PDF) |
| 207 | Prevalence of Pulmonary Embolism in Patients With Syncope | 2.6 | 30 | Citations (PDF) |
| 208 | Quantifying heart failure using natriuretic peptides may help the HEART team in decision-making | 2.2 | 8 | Citations (PDF) |
| 209 | Effects of Serelaxin in Patients with Acute Heart Failure | 25.5 | 205 | Citations (PDF) |
| 210 | Early Diagnosis of Myocardial Infarction in Patients With a History of Coronary Artery Bypass Grafting | 2.6 | 7 | Citations (PDF) |
| 211 | Outcome of Applying the ESC 0/1-hour Algorithm in Patients With Suspected Myocardial Infarction | 2.6 | 137 | Citations (PDF) |
| 212 | Application of High-Sensitivity Troponin in Suspected Myocardial Infarction | 25.5 | 256 | Citations (PDF) |
| 213 | Skeletal myopathies as a non-cardiac cause of elevations of cardiac troponin concentrations | 1.5 | 18 | Citations (PDF) |
| 214 | Clinical Utility of Procalcitonin in the Diagnosis of Pneumonia | 1.1 | 37 | Citations (PDF) |
| 215 | Predicting Acute Myocardial Infarction with a Single Blood Draw | 1.1 | 7 | Citations (PDF) |
| 216 | 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk | 1.2 | 1,935 | Citations (PDF) |
| 217 | CORT-AHF Study | 4.9 | 17 | Citations (PDF) |
| 218 | Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) | 2.6 | 182 | Citations (PDF) |
| 219 | Clinical Use of a New High-Sensitivity Cardiac Troponin I Assay in Patients with Suspected Myocardial Infarction | 1.1 | 44 | Citations (PDF) |
| 220 | Two-Hour Algorithm for Rapid Triage of Suspected Acute Myocardial Infarction Using a High-Sensitivity Cardiac Troponin I Assay | 1.1 | 35 | Citations (PDF) |
| 221 | Letter by Zimmermann et al Regarding Article, “Duration of Electrocardiographic Monitoring of Emergency Department Patients With Syncope” | 19.4 | 0 | Citations (PDF) |
| 222 | Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II | 2.5 | 3 | Citations (PDF) |
| 223 | Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure | 8.2 | 101 | Citations (PDF) |
| 224 | Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations | 8.2 | 516 | Citations (PDF) |
| 225 | Integrated Use of Conventional Chest Radiography Cannot Rule Out Acute Aortic Syndromes in Emergency Department Patients at Low Clinical Probability | 1.8 | 14 | Citations (PDF) |
| 226 | Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy | 8.2 | 280 | Citations (PDF) |
| 227 | Growth differentiation factor-15 and all-cause mortality in patients with suspected myocardial infarction | 2.2 | 7 | Citations (PDF) |
| 228 | Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study | 8.2 | 250 | Citations (PDF) |
| 229 | Diagnosis of acute myocardial infarction in the presence of left bundle branch blockHeart, 2019, 105, 1559-1567 | 2.8 | 27 | Citations (PDF) |
| 230 | Utility of Urine Neutrophil Gelatinase-Associated Lipocalin for Worsening Renal Function during Hospitalization for Acute Heart Failure: Primary Findings of the Urine N-gal Acute Kidney Injury N-gal Evaluation of Symptomatic Heart Failure Study (AKINESIS) | 1.3 | 24 | Citations (PDF) |
| 231 | Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure | 2.2 | 25 | Citations (PDF) |
| 232 | Diagnostic Accuracy of a High-Sensitivity Cardiac Troponin Assay with a Single Serum Test in the Emergency Department | 1.1 | 12 | Citations (PDF) |
| 233 | Letter by Hafner et al Regarding Article, “Safely Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge: HEART Pathway Accelerated Diagnostic Protocol” | 19.4 | 1 | Citations (PDF) |
| 234 | Cardiac Troponin in Stable Chest Pain | 2.6 | 0 | Citations (PDF) |
| 235 | Prospective validation of current quantitative electrocardiographic criteria for ST-elevation myocardial infarction | 2.2 | 34 | Citations (PDF) |
| 236 | Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology | 8.2 | 260 | Citations (PDF) |
| 237 | High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction | 1.1 | 62 | Citations (PDF) |
| 238 | Incidence and outcomes of unstable angina compared with non-ST-elevation myocardial infarctionHeart, 2019, 105, 1423-1431 | 2.8 | 43 | Citations (PDF) |
| 239 | Prospective validation of N‐terminal pro B‐type natriuretic peptide cut‐off concentrations for the diagnosis of acute heart failure | 8.2 | 12 | Citations (PDF) |
| 240 | Integration of transthoracic focused cardiac ultrasound in the diagnostic algorithm for suspected acute aortic syndromes | 2.2 | 48 | Citations (PDF) |
| 241 | Performance of a novel high sensitivity cardiac troponin I assay in asymptomatic hemodialysis patients – evidence for sex-specific differences | 2.7 | 6 | Citations (PDF) |
| 242 | Relative hypochromia and mortality in acute heart failure | 2.2 | 10 | Citations (PDF) |
| 243 | Prevalence and determinants of exercise‐induced left ventricular dysfunction in patients with coronary artery disease | 3.2 | 0 | Citations (PDF) |
| 244 | Perioperative major adverse cardiac events in urgent femoral artery repair after coronary stenting are less common than previously reported | 1.6 | 0 | Citations (PDF) |
| 245 | Validity of a Novel Point-of-Care Troponin Assay for Single-Test Rule-Out of Acute Myocardial Infarction | 9.7 | 0 | Citations (PDF) |
| 246 | Modified HEART Score and High-Sensitivity Cardiac Troponin in Patients With Suspected Acute Myocardial Infarction | 2.6 | 28 | Citations (PDF) |
| 247 | B-Type Natriuretic Peptides and Cardiac Troponins for Diagnosis and Risk-Stratification of Syncope | 19.4 | 39 | Citations (PDF) |
| 248 | Proenkephalin and prognosis in heart failure with preserved ejection fraction: a GREAT network study | 3.0 | 12 | Citations (PDF) |
| 249 | Symptoms Predictive of Acute Myocardial Infarction in the Troponin Era: Analysis From the TRAPID-AMI Study | 0.2 | 8 | Citations (PDF) |
| 250 | External Validation of the MEESSI Acute Heart Failure Risk Score | 10.5 | 43 | Citations (PDF) |
| 251 | B‐type natriuretic peptide trend predicts clinical significance of worsening renal function in acute heart failure | 8.2 | 36 | Citations (PDF) |
| 252 | Response by du Fay de Lavallaz et al to Letter Regarding Article, “B-Type Natriuretic Peptides and Cardiac Troponins for Diagnosis and Risk-Stratification of Syncope” | 19.4 | 6 | Citations (PDF) |
| 253 | Effect of a Strategy of Comprehensive Vasodilation vs Usual Care on Mortality and Heart Failure Rehospitalization Among Patients With Acute Heart Failure | 13.7 | 97 | Citations (PDF) |
| 254 | Reply | 2.6 | 0 | Citations (PDF) |
| 255 | Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays | 1.1 | 18 | Citations (PDF) |
| 256 | Impact of Food and Drug Administration Regulatory Approach on the 0/2-Hour Algorithm for Rapid Triage of Suspected Myocardial Infarction | 4.5 | 1 | Citations (PDF) |
| 257 | Clinical utility of circulating interleukin-6 concentrations in the detection of functionally relevant coronary artery disease | 2.2 | 12 | Citations (PDF) |
| 258 | Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction | 2.2 | 25 | Citations (PDF) |
| 259 | Inflammatory Biomarkers and Clinical Judgment in the Emergency Diagnosis of Urgent Abdominal Pain | 1.1 | 8 | Citations (PDF) |
| 260 | Comparison of fourteen rule-out strategies for acute myocardial infarction | 2.2 | 48 | Citations (PDF) |
| 261 | Daytime variation of perioperative myocardial injury in non-cardiac surgery and effect on outcomeHeart, 2019, 105, 826-833 | 2.8 | 14 | Citations (PDF) |
| 262 | Treatments targeting inotropy | 2.2 | 142 | Citations (PDF) |
| 263 | Comparative Analysis of Short-Term Outcomes of Patients With Heart Failure With a Mid-Range Ejection Fraction After Acute Decompensation | 1.9 | 12 | Citations (PDF) |
| 264 | Incremental diagnostic and prognostic value of the QRS-T angle, a 12-lead ECG marker quantifying heterogeneity of depolarization and repolarization, in patients with suspected non-ST-elevation myocardial infarction | 2.2 | 18 | Citations (PDF) |
| 265 | Optimising the early rule-out and rule-in of myocardial infarction using biomarkers | 0.0 | 3 | Citations (PDF) |
| 266 | Biomarkers in cardiovascular medicine: towards precision medicine | 1.5 | 10 | Citations (PDF) |
| 267 | Soluble ST2 – a new biomarker in heart failure | 0.0 | 7 | Citations (PDF) |
| 268 | Diagnostic value of the cardiac electrical biomarker, a novel <scp>ECG</scp> marker indicating myocardial injury, in patients with symptoms suggestive of non‐<scp>ST</scp>‐elevation myocardial infarction | 1.1 | 8 | Citations (PDF) |
| 269 | Impact of the US Food and Drug Administration–Approved Sex-Specific Cutoff Values for High-Sensitivity Cardiac Troponin T to Diagnose Myocardial Infarction | 19.4 | 20 | Citations (PDF) |
| 270 | Combining High-Sensitivity Cardiac Troponin I and Cardiac Troponin T in the Early Diagnosis of Acute Myocardial Infarction | 19.4 | 67 | Citations (PDF) |
| 271 | Automatically computed ECG algorithm for the quantification of myocardial scar and the prediction of mortality | 3.0 | 4 | Citations (PDF) |
| 272 | High-sensitivity cardiac troponin T for diagnosis of NSTEMI in the elderly emergency department patient: a clinical cohort study | 2.0 | 13 | Citations (PDF) |
| 273 | Modeling deformation and damage of rock salt using the discrete element method | 6.3 | 51 | Citations (PDF) |
| 274 | East Asia may have a better 1‐year survival following an acute heart failure episode compared with Europe: results from an international observational cohort | 8.2 | 12 | Citations (PDF) |
| 275 | Effect of Acute Coronary Syndrome Probability on Diagnostic and Prognostic Performance of High-Sensitivity Cardiac Troponin | 1.1 | 6 | Citations (PDF) |
| 276 | How is cardiac troponin released from injured myocardium? | 1.0 | 189 | Citations (PDF) |
| 277 | How to best use high-sensitivity cardiac troponin in patients with suspected myocardial infarction | 1.8 | 17 | Citations (PDF) |
| 278 | How accurate is clinical assessment of neck veins in the estimation of central venous pressure in acute heart failure? Insights from a prospective study | 8.2 | 19 | Citations (PDF) |
| 279 | Indications and practical approach to non-invasive ventilation in acute heart failure | 2.2 | 142 | Citations (PDF) |
| 280 | Reply | 1.6 | 0 | Citations (PDF) |
| 281 | Comprehensive in‐hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) | 8.2 | 63 | Citations (PDF) |
| 282 | Short-term outcomes of heart failure patients with reduced and preserved ejection fraction after acute decompensation according to the final destination after emergency department care | 3.0 | 16 | Citations (PDF) |
| 283 | Drug‐coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET‐SMALL 2 | 2.1 | 12 | Citations (PDF) |
| 284 | Reply | 2.6 | 0 | Citations (PDF) |
| 285 | What to do when you question cardiac troponin values | 1.0 | 68 | Citations (PDF) |
| 286 | Complement activation products in acute heart failure: Potential role in pathophysiology, responses to treatment and impacts on long-term survival | 1.0 | 7 | Citations (PDF) |
| 287 | Use of copeptin for rapid rule-out of acute myocardial infarction | 1.0 | 51 | Citations (PDF) |
| 288 | Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology | 8.2 | 260 | Citations (PDF) |
| 289 | Prospective Validation of a Biomarker-Based Rule Out Strategy for Functionally Relevant Coronary Artery Disease | 1.1 | 35 | Citations (PDF) |
| 290 | Diagnostic Accuracy of the Aortic Dissection Detection Risk Score Plus D-Dimer for Acute Aortic Syndromes | 19.4 | 207 | Citations (PDF) |
| 291 | Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity‐score matched study | 8.2 | 104 | Citations (PDF) |
| 292 | Cortisol Outperforms Novel Cardiovascular, Inflammatory, and Neurohumoral Biomarkers in the Prediction of Outcome in Acute Pancreatitis | 1.0 | 9 | Citations (PDF) |
| 293 | Perioperative Myocardial Injury After Noncardiac Surgery | 19.4 | 367 | Citations (PDF) |
| 294 | 0/1-Hour Triage Algorithm for Myocardial Infarction in Patients With Renal Dysfunction | 19.4 | 119 | Citations (PDF) |
| 295 | Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of inducible myocardial ischemia | 1.8 | 13 | Citations (PDF) |
| 296 | Risk stratification in acute heart failure | 8.2 | 1 | Citations (PDF) |
| 297 | Characteristics and occurrence of type 2 myocardial infarction in emergency department patients: a prospective study | 0.9 | 22 | Citations (PDF) |
| 298 | Is There Any Relationship between TSH Levels and Prognosis in Acute Coronary
Syndrome? | 0.6 | 7 | Citations (PDF) |
| 299 | Design of the randomized, placebo‐controlled evolocumab for early reduction of LDL‐cholesterol levels in patients with acute coronary syndromes (EVOPACS) trial | 2.1 | 23 | Citations (PDF) |
| 300 | Letter by Nestelberger et al Regarding Article, “Association Between Early Hyperoxia Exposure After Resuscitation from Cardiac Arrest and Neurological Disability: Prospective Multicenter Protocol-Directed Cohort Study” | 19.4 | 0 | Citations (PDF) |
| 301 | Response by Morello et al to Letters Regarding Article, “Diagnostic Accuracy of the Aortic Dissection Detection Risk Score Plus D–Dimer for Acute Aortic Syndromes: The ADvISED Prospective Multicenter Study” | 19.4 | 7 | Citations (PDF) |
| 302 | Response by Kaier et al to Letter Regarding Article, “Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction” | 19.4 | 2 | Citations (PDF) |
| 303 | Rhabdomyolysis | 2.6 | 16 | Citations (PDF) |
| 304 | Response by Puelacher and Mueller to Letters Regarding Article, “Perioperative Myocardial Injury After Noncardiac Surgery: Incidence, Mortality, and Characterization” | 19.4 | 1 | Citations (PDF) |
| 305 | Type 2 myocardial infarction | 2.2 | 2 | Citations (PDF) |
| 306 | Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction | 2.2 | 91 | Citations (PDF) |
| 307 | Peri-operative copeptin concentrations and their association with myocardial injury after vascular surgery | 5.6 | 12 | Citations (PDF) |
| 308 | Clinical Validation of a Novel High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction | 1.1 | 124 | Citations (PDF) |
| 309 | Amyloid-β (1-40) and Mortality in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome | 10.5 | 35 | Citations (PDF) |
| 310 | Update on high-sensitivity cardiac troponin in patients with suspected myocardial infarction | 0.3 | 14 | Citations (PDF) |
| 311 | Prospective Validation of the 0/1-h Algorithm for Early Diagnosis of Myocardial Infarction | 2.6 | 156 | Citations (PDF) |
| 312 | Time to Diuretic in Acute Heart Failure | 4.9 | 1 | Citations (PDF) |
| 313 | Prospective validation of prognostic and diagnostic syncope scores in the emergency department | 2.2 | 17 | Citations (PDF) |
| 314 | Proenkephalin for the early detection of acute kidney injury in hospitalized patients with chronic kidney disease | 3.2 | 12 | Citations (PDF) |
| 315 | Comparison of high-sensitivity cardiac troponin I and T for the prediction of cardiac complications after non-cardiac surgery | 2.9 | 41 | Citations (PDF) |
| 316 | Direct Comparison of Cardiac Troponin T and I Using a Uniform and a Sex-Specific Approach in the Detection of Functionally Relevant Coronary Artery Disease | 1.1 | 21 | Citations (PDF) |
| 317 | Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial | 35.3 | 290 | Citations (PDF) |
| 318 | Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production | 11.4 | 73 | Citations (PDF) |
| 319 | Direct Comparison of the 0/1h and 0/3h Algorithms for Early Rule-Out of Acute Myocardial Infarction | 19.4 | 48 | Citations (PDF) |
| 320 | Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis | 3.0 | 17 | Citations (PDF) |
| 321 | B From bench to improved diagnosis of AMI – cardiac myosin-binding protein C 2018, , A111.2-A112 | | 1 | Citations (PDF) |
| 322 | Diagnostic and prognostic value of QRS duration and QTc interval in patients with suspected myocardial infarction | 1.3 | 16 | Citations (PDF) |
| 323 | European Society of Cardiology-Acute Cardiovascular Care Association Position paper on acute heart failure: A call for interdisciplinary care | 1.0 | 44 | Citations (PDF) |
| 324 | Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care? | 1.0 | 22 | Citations (PDF) |
| 325 | European Society of Cardiology – Acute Cardiovascular Care Association position paper on safe discharge of acute heart failure patients from the emergency department | 1.0 | 56 | Citations (PDF) |
| 326 | How to use D-dimer in acute cardiovascular care | 1.0 | 59 | Citations (PDF) |
| 327 | Editor’s Choice-Rule-in of acute myocardial infarction: Focus on troponin | 1.0 | 35 | Citations (PDF) |
| 328 | Rapid rule out of acute myocardial infarction: novel biomarker-based strategies | 1.0 | 70 | Citations (PDF) |
| 329 | Diagnostic and Prognostic Value of Lead aVR During Exercise Testing in Patients Suspected of Having Myocardial Ischemia | 1.9 | 11 | Citations (PDF) |
| 330 | Ticagrelor induced systemic inflammatory response syndrome | 2.1 | 2 | Citations (PDF) |
| 331 | Direct Comparison of 4 Very Early Rule-Out Strategies for Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin I | 19.4 | 137 | Citations (PDF) |
| 332 | Early diagnosis of acute myocardial infarction in patients with mild elevations of cardiac troponin | 3.0 | 36 | Citations (PDF) |
| 333 | Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Diagnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation | 1.1 | 31 | Citations (PDF) |
| 334 | Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the Emergency Department | 4.5 | 62 | Citations (PDF) |
| 335 | Diagnostic and prognostic values of the V-index, a novel ECG marker quantifying spatial heterogeneity of ventricular repolarization, in patients with symptoms suggestive of non-ST-elevation myocardial infarction | 2.2 | 17 | Citations (PDF) |
| 336 | Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin | 2.5 | 215 | Citations (PDF) |
| 337 | Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure | 4.9 | 102 | Citations (PDF) |
| 338 | The GALA study: relationship between galectin-3 serum levels and short- and long-term outcomes of patients with acute heart failure | 2.0 | 23 | Citations (PDF) |
| 339 | Letter by Mueller and Roffi Regarding Article, “Assessment of the European Society of Cardiology 0-Hour/1-Hour Algorithm to Rule-Out and Rule-In Acute Myocardial Infarction” | 19.4 | 0 | Citations (PDF) |
| 340 | Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection | 10.5 | 231 | Citations (PDF) |
| 341 | Echocardiography and lung ultrasonography for the assessment and management of acute heart failure | 12.5 | 150 | Citations (PDF) |
| 342 | Direct Comparison of 2 Rule-Out Strategies for Acute Myocardial Infarction: 2-h Accelerated Diagnostic Protocol vs 2-h Algorithm | 1.1 | 34 | Citations (PDF) |
| 343 | The relationship of circulating relaxin‐2 concentrations with short‐term prognosis in patients with acute heart failure: the RELAHF study | 8.2 | 5 | Citations (PDF) |
| 344 | Clinical utility of biomarkers in heart failure | 8.2 | 4 | Citations (PDF) |
| 345 | Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) | 8.2 | 273 | Citations (PDF) |
| 346 | Effect of phosphodiesterase-5 inhibition with Tadalafil on SystEmic Right VEntricular size and function – A multi-center, double-blind, randomized, placebo-controlled clinical trial – SERVE trial - Rational and design | 2.2 | 17 | Citations (PDF) |
| 347 | Diagnostic value of ST-segment deviations during cardiac exercise stress testing: Systematic comparison of different ECG leads and time-points | 2.2 | 9 | Citations (PDF) |
| 348 | What can we learn from SOCRATES: more questions than answers? | 2.2 | 7 | Citations (PDF) |
| 349 | Letter to the Editor: “High sensitive cardiac troponin T: Testing the test” | 2.2 | 0 | Citations (PDF) |
| 350 | The Effect of Frailty on 30‐day Mortality Risk in Older Patients With Acute Heart Failure Attended in the Emergency Department | 1.8 | 40 | Citations (PDF) |
| 351 | Diagnostic performance of a high-sensitive troponin T assay and a troponin T point of care assay in the clinical routine of an Emergency Department: A clinical cohort study | 2.2 | 18 | Citations (PDF) |
| 352 | Comparison of the Efficacy and Safety of Early Rule-Out Pathways for Acute Myocardial Infarction | 19.4 | 157 | Citations (PDF) |
| 353 | Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure | 2.6 | 70 | Citations (PDF) |
| 354 | An algorithm for rule-in and rule-out of acute myocardial infarction using a novel troponin I assayHeart, 2017, 103, 125-131 | 2.8 | 16 | Citations (PDF) |
| 355 | Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction | 19.4 | 67 | Citations (PDF) |
| 356 | High-sensitivity Cardiac Troponin: A Novel Window to the Heart | 1.1 | 1 | Citations (PDF) |
| 357 | Effect of Definition on Incidence and Prognosis of Type 2 Myocardial Infarction | 2.6 | 93 | Citations (PDF) |
| 358 | Origin of Cardiac Troponin T Elevations in Chronic Kidney Disease | 19.4 | 43 | Citations (PDF) |
| 359 | Effect of the FDA Regulatory Approach on the 0/1-h Algorithm for Rapid Diagnosis of MI | 2.6 | 16 | Citations (PDF) |
| 360 | Sacubitril/valsartan in PARADIGM-HF | 22.3 | 1 | Citations (PDF) |
| 361 | Diagnostic and prognostic value of cystatin C in acute heart failure | 1.8 | 28 | Citations (PDF) |
| 362 | Prediction of major cardiac events after vascular surgery | 1.6 | 26 | Citations (PDF) |
| 363 | Transcriptome-Wide Analysis Identifies Novel Associations With Blood Pressure | 7.0 | 39 | Citations (PDF) |
| 364 | Clinical Use of High-Sensitivity Cardiac Troponin in Patients With Suspected Myocardial Infarction | 2.6 | 194 | Citations (PDF) |
| 365 | Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome | 13.7 | 197 | Citations (PDF) |
| 366 | Mortality and acute exacerbation of COPD: a pilot study on the influence of myocardial injury | 7.7 | 7 | Citations (PDF) |
| 367 | Necessity of hospitalization and stress testing in low risk chest pain patients | 1.6 | 5 | Citations (PDF) |
| 368 | EAHFE – TROPICA2 study. Prognostic value of troponin in patients with acute heart failure treated in Spanish hospital emergency departments | 2.0 | 13 | Citations (PDF) |
| 369 | Impact of haemoconcentration during acute heart failure therapy on mortality and its relationship with worsening renal function | 8.2 | 60 | Citations (PDF) |
| 370 | Prohormones in the Early Diagnosis of Cardiac Syncope | 4.3 | 15 | Citations (PDF) |
| 371 | Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications | 3.0 | 28 | Citations (PDF) |
| 372 | Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency department | 2.5 | 48 | Citations (PDF) |
| 373 | Quantification of Renal Function and Cardiovascular Mortality in Patients Admitted to the Emergency Department with Suspected Acute Coronary Syndromes: | 0.4 | 2 | Citations (PDF) |
| 374 | Diurnal Rhythm of Cardiac Troponin: Consequences for the Diagnosis of Acute Myocardial Infarction | 1.1 | 74 | Citations (PDF) |
| 375 | Multimarker assessment for the prediction of renal function improvement after percutaneous revascularization for renal artery stenosis | 1.8 | 2 | Citations (PDF) |
| 376 | The Use of Very Low Concentrations of High‐sensitivity Troponin T to Rule Out Acute Myocardial Infarction Using a Single Blood Test | 1.8 | 61 | Citations (PDF) |
| 377 | BETAWIN-AHF study: effect of beta-blocker withdrawal during acute decompensation in patients with chronic heart failure | 3.0 | 19 | Citations (PDF) |
| 378 | Enlarging Red Blood Cell Distribution Width During Hospitalization Identifies a Very High-Risk Subset of Acutely Decompensated Heart Failure Patients and Adds Valuable Prognostic Information on Top of Hemoconcentration | 1.3 | 17 | Citations (PDF) |
| 379 | Biomarkers of cardiovascular stress in obstructive sleep apnea | 1.2 | 27 | Citations (PDF) |
| 380 | Incremental Value of Preoperative Copeptin for Predicting Myocardial Injury | 1.8 | 21 | Citations (PDF) |
| 381 | Should the 1h algorithm for rule in and rule out of acute myocardial infarction be used universally?Sometimes earlier may not be betterBackground, fundamental concepts, and scientific evidence of the high-sensitivity cardiac troponin 0h/1h-algorithm for early rule-out or rule-in of acute myocardial infarction | 2.2 | 26 | Citations (PDF) |
| 382 | Relationship of N-Terminal fragment of Pro-B-Type Natriuretic Peptide and copeptin with erythrocytes-related parameters: A population-based study | 1.8 | 2 | Citations (PDF) |
| 383 | Incremental value of copeptin in suspected acute myocardial infarction very early after symptom onset | 1.0 | 22 | Citations (PDF) |
| 384 | Clinical impact of the 2010–2012 low-end shift of high-sensitivity cardiac troponin T | 1.0 | 20 | Citations (PDF) |
| 385 | Safety and efficacy of the 0 h/3 h protocol for rapid rule out of myocardial infarction | 2.9 | 63 | Citations (PDF) |
| 386 | In reply: | 0.7 | 0 | Citations (PDF) |
| 387 | Meta-Analysis of Individual Patient Data of Sodium Bicarbonate and Sodium Chloride for All-Cause Mortality After Coronary Angiography | 1.9 | 4 | Citations (PDF) |
| 388 | Clinical Effect of Sex-Specific Cutoff Values of High-Sensitivity Cardiac Troponin T in Suspected Myocardial Infarction | 9.7 | 80 | Citations (PDF) |
| 389 | Intersubject variability and intrasubject reproducibility of 12-lead ECG metrics: Implications for human verification | 0.9 | 17 | Citations (PDF) |
| 390 | Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology | 8.2 | 518 | Citations (PDF) |
| 391 | Heart failure epidemiology 2000–2013: insights from the German Federal Health Monitoring System | 8.2 | 116 | Citations (PDF) |
| 392 | Copeptin for the early rule-out of non-ST-elevation myocardial infarction | 2.2 | 26 | Citations (PDF) |
| 393 | State-of-the-Art Evaluation of Emergency Department Patients Presenting With Potential Acute Coronary Syndromes | 19.4 | 84 | Citations (PDF) |
| 394 | Inter-lead correlation analysis for automated detection of cable reversals in 12/16-lead ECG | 5.5 | 17 | Citations (PDF) |
| 395 | Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations | 2.6 | 84 | Citations (PDF) |
| 396 | Practical approach on frail older patients attended for acute heart failure | 2.2 | 48 | Citations (PDF) |
| 397 | Influence of Gender and Copeptin Levels on Clinical Outcomes in Patients With Acute Heart Failure | 1.3 | 1 | Citations (PDF) |
| 398 | Diagnostic and Prognostic Utility of Circulating Cytochrome
<i>c</i>
in Acute Myocardial Infarction | 12.8 | 16 | Citations (PDF) |
| 399 | Measurement of cardiac troponin for exclusion of myocardial infarction | 35.3 | 4 | Citations (PDF) |
| 400 | Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour Algorithm | 9.7 | 191 | Citations (PDF) |
| 401 | Incremental value of heart-type fatty acid-binding protein in suspected acute myocardial infarction early after symptom onset | 1.0 | 16 | Citations (PDF) |
| 402 | Two-Hour Algorithm for Triage toward Rule-Out and Rule-In of Acute Myocardial Infarction by Use of High-Sensitivity Cardiac Troponin I | 1.1 | 97 | Citations (PDF) |
| 403 | Incidence and Predictors of Cardiomyocyte Injury in Elective Coronary Angiography | 2.1 | 5 | Citations (PDF) |
| 404 | Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T | 0.7 | 289 | Citations (PDF) |
| 405 | Characterization of the observe zone of the ESC 2015 high-sensitivity cardiac troponin 0 h/1 h-algorithm for the early diagnosis of acute myocardial infarction | 2.2 | 89 | Citations (PDF) |
| 406 | Ventricular conduction abnormalities as predictors of long‐term survival in acute <i>de novo</i> and decompensated chronic heart failure | 3.4 | 13 | Citations (PDF) |
| 407 | Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T — Sub-analysis from the TRAPID-AMI study | 2.2 | 103 | Citations (PDF) |
| 408 | Clinical benefit of high-sensitivity cardiac troponin I in the detection of exercise-induced myocardial ischemia | 2.9 | 56 | Citations (PDF) |
| 409 | Direct comparison of cardiac troponin I and cardiac troponin T in the detection of exercise-induced myocardial ischemia | 1.8 | 22 | Citations (PDF) |
| 410 | Prognostic Value of Undetectable hs Troponin T in Suspected Acute Coronary Syndrome | 2.1 | 28 | Citations (PDF) |
| 411 | One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I | 2.9 | 95 | Citations (PDF) |
| 412 | 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation | 2.2 | 5,576 | Citations (PDF) |
| 413 | Serial sampling of copeptin levels improves diagnosis and risk stratification in patients presenting with chest pain: results from the CHOPIN trial | 0.9 | 9 | Citations (PDF) |
| 414 | Editor’s Choice- Call to action: Initiation of multidisciplinary care for acute heart failure begins in the Emergency Department | 1.0 | 14 | Citations (PDF) |
| 415 | Factors independently associated with cardiac troponin I levels in young and healthy adults from the general population | 3.0 | 21 | Citations (PDF) |
| 416 | Gender-specific uncertainties in the diagnosis of acute coronary syndrome | 3.0 | 15 | Citations (PDF) |
| 417 | Impact of high-sensitivity cardiac troponin on use of coronary angiography, cardiac stress testing, and time to discharge in suspected acute myocardial infarction | 2.2 | 141 | Citations (PDF) |
| 418 | Advanced ECG in 2016: is there more than just a tracing? | 1.5 | 22 | Citations (PDF) |
| 419 | Recommendations on pre‐hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine | 8.2 | 320 | Citations (PDF) |
| 420 | Midregional Proadrenomedullin Predicts Mortality and Major Adverse Cardiac Events in Patients Presenting With Chest Pain: Results From the <scp>CHOPIN</scp> Trial | 1.8 | 10 | Citations (PDF) |
| 421 | Sex-Specific Chest Pain Characteristics—Reply | 8.9 | 0 | Citations (PDF) |
| 422 | 2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation | 0.5 | 60 | Citations (PDF) |
| 423 | Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohort | 8.2 | 47 | Citations (PDF) |
| 424 | Delayed release of brain natriuretic peptide to identify myocardial ischaemia | 3.2 | 9 | Citations (PDF) |
| 425 | Platelet function testing in acute cardiac care – is there a role for prediction or prevention of stent thrombosis and bleeding? | 4.4 | 32 | Citations (PDF) |
| 426 | Agents with vasodilator properties in acute heart failure: how to design successful trials | 8.2 | 22 | Citations (PDF) |
| 427 | Prognostic Value of Pentraxin-3 Level in Patients with STEMI and Its Relationship with Heart Failure and Markers of Oxidative Stress | 1.7 | 21 | Citations (PDF) |
| 428 | Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4 | 4.4 | 35 | Citations (PDF) |
| 429 | Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine – short version | 2.2 | 112 | Citations (PDF) |
| 430 | Early rule-out and rule-in of myocardial infarction using sensitive cardiac Troponin I | 2.2 | 29 | Citations (PDF) |
| 431 | How does a clinical trial fit into the real world? The RELAX-AHF study population into the EAHFE registry | 3.0 | 27 | Citations (PDF) |
| 432 | Long-Term Efficacy and Safety of Biodegradable-Polymer Biolimus-Eluting Stents | 19.4 | 85 | Citations (PDF) |
| 433 | Accelerated diagnostic protocol using high-sensitivity cardiac troponin T in acute chest pain patients | 2.2 | 43 | Citations (PDF) |
| 434 | Cardiac troponin elevations in acute non-coronary disease: Helpful or not? | 1.0 | 1 | Citations (PDF) |
| 435 | Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST | 1.1 | 25 | Citations (PDF) |
| 436 | Beyond cardiac troponin: recent advances in the development of alternative biomarkers for cardiovascular disease | 3.1 | 6 | Citations (PDF) |
| 437 | Diagnostic and Prognostic Value of High-sensitivity Cardiac Troponin T in Patients with Syncope | 2.1 | 17 | Citations (PDF) |
| 438 | Multimarker Testing With ST2 in Chronic Heart Failure | 1.9 | 21 | Citations (PDF) |
| 439 | Sex-specific cutoffs for cardiac troponin using high-sensitivity assays — Is there clinical equipoise? | 1.8 | 13 | Citations (PDF) |
| 440 | Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure | 2.2 | 43 | Citations (PDF) |
| 441 | Incremental Value of a Single High-sensitivity Cardiac Troponin I Measurement to Rule Out Myocardial Ischemia | 2.1 | 31 | Citations (PDF) |
| 442 | Cardiomyocyte injury induced by hemodynamic cardiac stress: Differential release of cardiac biomarkers | 1.8 | 11 | Citations (PDF) |
| 443 | Comment on “Is Addition of Vasodilators to Loop Diuretics of Value in the Care of Hospitalized Acute Heart Failure Patients? Real-World Evidence from a Retrospective Analysis of a Large United States Hospital Database” | 1.3 | 0 | Citations (PDF) |
| 444 | B-type natriuretic peptide secretion without change in intra-cardiac pressure | 1.8 | 2 | Citations (PDF) |
| 445 | Incremental value of copeptin to highly sensitive cardiac Troponin I for rapid rule-out of myocardial infarction | 2.2 | 37 | Citations (PDF) |
| 446 | Serial ST2 Testing in Hospitalized Patients With Acute Heart Failure | 1.9 | 29 | Citations (PDF) |
| 447 | Effects of hemolysis on the diagnostic accuracy of cardiac troponin I for the diagnosis of myocardial infarction | 2.2 | 8 | Citations (PDF) |
| 448 | Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assayCmaj, 2015, 187, E243-E252 | 1.4 | 188 | Citations (PDF) |
| 449 | Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac Troponin | 19.4 | 115 | Citations (PDF) |
| 450 | Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction | 19.4 | 171 | Citations (PDF) |
| 451 | One-hour Rule-in and Rule-out of Acute Myocardial Infarction Using High-sensitivity Cardiac Troponin I | 2.1 | 167 | Citations (PDF) |
| 452 | Sex differences of troponin test performance in chest pain patients | 2.2 | 25 | Citations (PDF) |
| 453 | Diagnostic and prognostic value of autoantibodies anti‐apolipoprotein A‐1 and anti‐phosphorylcholine in acute non‐<scp>ST</scp> elevation myocardial infarction | 3.2 | 9 | Citations (PDF) |
| 454 | Temporal Release Pattern of Copeptin and Troponin T in Patients with Suspected Acute Coronary Syndrome and Spontaneous Acute Myocardial Infarction | 1.1 | 42 | Citations (PDF) |
| 455 | Optimizing Early Rule-Out Strategies for Acute Myocardial Infarction: Utility of 1-Hour Copeptin | 1.1 | 14 | Citations (PDF) |
| 456 | Prediction of mortality using quantification of renal function in acute heart failure | 2.2 | 20 | Citations (PDF) |
| 457 | Comparison of conventional and high-sensitivity troponin in patients with chest pain: A collaborative meta-analysis | 2.9 | 85 | Citations (PDF) |
| 458 | Relationship Between High-Sensitivity Cardiac Troponin I and Blood Pressure Among Young and Healthy Adults | 2.2 | 35 | Citations (PDF) |
| 459 | Incidence and timing of serious arrhythmias after early revascularization in non ST-elevation myocardial infarction | 1.0 | 5 | Citations (PDF) |
| 460 | How acute changes in cardiac troponin concentrations help to handle the challenges posed by troponin elevations in non-ACS-patients | 1.8 | 18 | Citations (PDF) |
| 461 | Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study | 2.2 | 185 | Citations (PDF) |
| 462 | Two-hour Algorithm for Triage Toward Rule-out and Rule-in of Acute Myocardial Infarction Using High-sensitivity Cardiac Troponin T | 2.1 | 117 | Citations (PDF) |
| 463 | Comprehensive biomarker profiling in patients with obstructive sleep apnea | 1.8 | 42 | Citations (PDF) |
| 464 | Biomarker-guided personalised emergency medicine for all – hope for another hype? | 1.5 | 60 | Citations (PDF) |
| 465 | 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation | 0.6 | 107 | Citations (PDF) |
| 466 | Plasma Concentrations of the Vasoactive Peptide Fragments Mid-Regional Pro-Adrenomedullin, C-Terminal Pro-Endothelin 1 and Copeptin in Hemodialysis Patients: Associated Factors and Prediction of Mortality | 2.5 | 15 | Citations (PDF) |
| 467 | Prognostic Value and Link to Atrial Fibrillation of Soluble Klotho and FGF23 in Hemodialysis Patients | 2.5 | 58 | Citations (PDF) |
| 468 | BNP but Not s-cTnln Is Associated with Cardioembolic Aetiology and Predicts Short and Long Term Prognosis after Cerebrovascular Events | 2.5 | 31 | Citations (PDF) |
| 469 | Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis | 1.0 | 96 | Citations (PDF) |
| 470 | Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays | 2.2 | 85 | Citations (PDF) |
| 471 | Prevalence, characteristics and outcome of non-cardiac chest pain and elevated copeptin levelsHeart, 2014, 100, 1708-1714 | 2.8 | 19 | Citations (PDF) |
| 472 | High-sensitivity cardiac troponin in acute conditions | 3.6 | 38 | Citations (PDF) |
| 473 | Sex-Specific Chest Pain Characteristics in the Early Diagnosis of Acute Myocardial Infarction | 8.9 | 125 | Citations (PDF) |
| 474 | Midregional pro-adrenomedullin and copeptin: exercise kinetics and association with the cardiopulmonary exercise response in comparison to B-type natriuretic peptide | 2.1 | 11 | Citations (PDF) |
| 475 | Clevidipine in acute heart failure: Results of the A Study of Blood Pressure Control in Acute Heart Failure—A Pilot Study (PRONTO) | 2.9 | 75 | Citations (PDF) |
| 476 | Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction | 2.2 | 168 | Citations (PDF) |
| 477 | Biomarkers and acute coronary syndromes: an update | 2.2 | 170 | Citations (PDF) |
| 478 | Incremental value of B-type natriuretic peptide for early risk prediction of infective endocarditis | 2.2 | 13 | Citations (PDF) |
| 479 | Galectin-3: A Modifiable Risk Factor in Heart Failure | 2.2 | 62 | Citations (PDF) |
| 480 | Assessment of microRNAs in patients with unstable angina pectoris | 2.2 | 115 | Citations (PDF) |
| 481 | Novel insights into the pathophysiology of different forms of stress testing | 1.8 | 8 | Citations (PDF) |
| 482 | Body Mass Index and Mortality in Acutely Decompensated Heart Failure Across the World | 2.6 | 214 | Citations (PDF) |
| 483 | Utility of C-terminal Proendothelin in the Early Diagnosis and Risk Stratification of Patients With Suspected Acute Myocardial Infarction | 1.9 | 9 | Citations (PDF) |
| 484 | A Systematic Review and Collaborative Meta-Analysis to Determine the Incremental Value of Copeptin for Rapid Rule-Out of Acute Myocardial Infarction | 1.9 | 115 | Citations (PDF) |
| 485 | In search for the Holy Grail: Suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: a position paper from the study group on biomarkers of the Acute Cardiovascular Care Association | 1.0 | 30 | Citations (PDF) |
| 486 | B-type Natriuretic Peptide and Clinical Judgment in the Detection of Exercise-induced Myocardial Ischemia | 2.1 | 17 | Citations (PDF) |
| 487 | Accuracy of very low concentration of cTn, below the 99th, for the diagnosis of acute myocardial infarction: Comments about Lippi's and coll. letter | 2.2 | 0 | Citations (PDF) |
| 488 | What Cardiologists Should Know About Copeptin | 0.5 | 6 | Citations (PDF) |
| 489 | Association of Adrenal Function and Disease Severity in Community-Acquired Pneumonia | 2.5 | 20 | Citations (PDF) |
| 490 | Incremental value of multiplex real-time PCR for the early diagnosis of sepsis in the emergency department | 1.5 | 8 | Citations (PDF) |
| 491 | Copeptin Helps in the Early Detection of Patients With Acute Myocardial Infarction | 2.6 | 152 | Citations (PDF) |
| 492 | Comparison of the performances of cardiac troponins, including sensitive assays, and copeptin in the diagnostic of acute myocardial infarction and long-term prognosis between women and men | 2.9 | 57 | Citations (PDF) |
| 493 | Atrial Fibrillation Impairs the Diagnostic Performance of Cardiac Natriuretic Peptides in Dyspneic Patients | 4.9 | 107 | Citations (PDF) |
| 494 | Does hypoxemia have an impact on the cardiac release and circulating concentrations of natriuretic peptides in humans in vivo? | 2.2 | 2 | Citations (PDF) |
| 495 | Normal presenting levels of high-sensitivity troponin and myocardial infarctionHeart, 2013, 99, 1567-1572 | 2.8 | 35 | Citations (PDF) |
| 496 | Risk stratification in patients with unstable angina using absolute serial changes of 3 high-sensitive troponin assays | 2.9 | 68 | Citations (PDF) |
| 497 | Prevalence, Extent, and Independent Predictors of Silent Myocardial Infarction | 2.1 | 55 | Citations (PDF) |
| 498 | Troponin testing: End of an era? | 1.8 | 3 | Citations (PDF) |
| 499 | Utility of 14 novel biomarkers in patients with acute chest pain and undetectable levels of conventional cardiac troponin | 2.2 | 13 | Citations (PDF) |
| 500 | Association Between Elevated Blood Glucose and Outcome in Acute Heart Failure | 2.6 | 105 | Citations (PDF) |
| 501 | Heart Failure Therapy–Induced Early ST2 Changes May Offer Long-Term Therapy Guidance | 1.3 | 67 | Citations (PDF) |
| 502 | Serial changes in high-sensitivity cardiac troponin I in the early diagnosis of acute myocardial infarction | 2.2 | 28 | Citations (PDF) |
| 503 | Consideration of high-sensitivity troponin values below the 99th percentile at presentation: Does it improve diagnostic accuracy? | 2.2 | 19 | Citations (PDF) |
| 504 | Validation of High-Sensitivity Troponin I in a 2-Hour Diagnostic Strategy to Assess 30-Day Outcomes in Emergency Department Patients With Possible Acute Coronary Syndrome | 2.6 | 272 | Citations (PDF) |
| 505 | Mid-regional pro-adrenomedullin in the early evaluation of acute chest pain patients | 2.2 | 10 | Citations (PDF) |
| 506 | Early Diagnosis of Myocardial Infarction Using Absolute and Relative Changes in Cardiac Troponin Concentrations | 2.1 | 42 | Citations (PDF) |
| 507 | The Reply | 2.1 | 0 | Citations (PDF) |
| 508 | Uric acid for diagnosis and risk stratification in suspected myocardial infarction | 3.2 | 7 | Citations (PDF) |
| 509 | Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study | 2.2 | 201 | Citations (PDF) |
| 510 | Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin | 2.2 | 165 | Citations (PDF) |
| 511 | Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery | 2.2 | 161 | Citations (PDF) |
| 512 | Use of high-sensitivity troponin for the diagnosis of acute myocardial infarction | 1.0 | 5 | Citations (PDF) |
| 513 | Biomarkers and ST-elevation myocardial infarctionHeart, 2013, 99, 1143-1143 | 2.8 | 1 | Citations (PDF) |
| 514 | Testing Times: We Are Still Some Way From Getting the Best Out of Sensitive Troponin Assays—Reply | 8.9 | 1 | Citations (PDF) |
| 515 | Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction | 2.8 | 72 | Citations (PDF) |
| 516 | Counterpoint: Detection of Myocardial Infarction—Is It All Troponin? Role of New Markers | 1.1 | 6 | Citations (PDF) |
| 517 | Growth Differentiation Factor-15 in the Early Diagnosis and Risk Stratification of Patients with Acute Chest Pain | 1.1 | 35 | Citations (PDF) |
| 518 | Response to Letter Regarding Article, “Utility of Absolute and Relative Changes in Cardiac Troponin Concentrations in the Early Diagnosis of Acute Myocardial Infarction” | 19.4 | 0 | Citations (PDF) |
| 519 | Happy birthday BNP | 1.0 | 1 | Citations (PDF) |
| 520 | ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC | 2.2 | 5,013 | Citations (PDF) |
| 521 | Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoeaHeart, 2012, 98, 1518-1522 | 2.8 | 18 | Citations (PDF) |
| 522 | High-Sensitivity Cardiac Troponin in the Distinction of Acute Myocardial Infarction From Acute Cardiac Noncoronary Artery Disease | 19.4 | 137 | Citations (PDF) |
| 523 | Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study | 8.2 | 46 | Citations (PDF) |
| 524 | Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial | 8.2 | 116 | Citations (PDF) |
| 525 | Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction | 2.8 | 61 | Citations (PDF) |
| 526 | Quantifying Cardiac Hemodynamic Stress and Cardiomyocyte Damage in Ischemic and Nonischemic Acute Heart Failure | 4.8 | 18 | Citations (PDF) |
| 527 | How Safe Is the Outpatient Management of Patients with Acute Chest Pain and Mildly Increased Cardiac Troponin Concentrations? | 1.1 | 23 | Citations (PDF) |
| 528 | Third universal definition of myocardial infarction | 2.2 | 2,379 | Citations (PDF) |
| 529 | Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays | 2.2 | 89 | Citations (PDF) |
| 530 | Why all the struggle about CK-MB and PCI? | 2.2 | 36 | Citations (PDF) |
| 531 | Direct Comparison of Three Natriuretic Peptides for Prediction of Short- and Long-term Mortality in Patients With Community-Acquired PneumoniaChest, 2012, 141, 974-982 | 0.5 | 57 | Citations (PDF) |
| 532 | Baseline Platelet Count and Clinical Outcome in Acute Coronary Syndrome | 1.8 | 20 | Citations (PDF) |
| 533 | High-sensitive troponin T measurements: what do we gain and what are the challenges? | 2.2 | 190 | Citations (PDF) |
| 534 | Introduction of High-sensitivity Troponin Assays: Impact on Myocardial Infarction Incidence and Prognosis | 2.1 | 164 | Citations (PDF) |
| 535 | Pathophysiology of Lower Extremity Edema in Acute Heart Failure Revisited | 2.1 | 26 | Citations (PDF) |
| 536 | One-Hour Rule-out and Rule-in of Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin T | 8.9 | 437 | Citations (PDF) |
| 537 | Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure | 6.9 | 32 | Citations (PDF) |
| 538 | Recommendations for the use of natriuretic peptides in acute cardiac care: A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care | 2.2 | 227 | Citations (PDF) |
| 539 | The effect of diabetes on the diagnostic and prognostic performance of mid-region pro-atrial natriuretic peptide and mid-region pro-adrenomedullin in patients with acute dyspnea | 2.0 | 4 | Citations (PDF) |
| 540 | ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 | 8.2 | 2,205 | Citations (PDF) |
| 541 | The novel marker LTBP2 predicts all-cause and pulmonary death in patients with acute dyspnoea | 6.3 | 19 | Citations (PDF) |
| 542 | Combined copeptin and troponin to rule out myocardial infarction in patients with chest pain and a history of coronary artery disease | 1.6 | 49 | Citations (PDF) |
| 543 | The Reply | 2.1 | 1 | Citations (PDF) |
| 544 | Determinants of High-Sensitivity Troponin T Among Patients with a Noncardiac Cause of Chest Pain | 2.1 | 62 | Citations (PDF) |
| 545 | How to use high-sensitivity cardiac troponins in acute cardiac care | 2.2 | 658 | Citations (PDF) |
| 546 | Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction: a post-hoc analysis of a multicenter randomized controlled trial | 2.2 | 4 | Citations (PDF) |
| 547 | Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: a randomized controlled trial | 2.2 | 76 | Citations (PDF) |
| 548 | Third Universal Definition of Myocardial Infarction | 2.6 | 2,488 | Citations (PDF) |
| 549 | ST-segment deviation score in the early diagnosis of acute myocardial infarction | 0.9 | 1 | Citations (PDF) |
| 550 | Mid-Regional Pro-Adrenomedullin in Acute Heart Failure: A Better Biomarker or Just Another Biomarker? | 3.0 | 32 | Citations (PDF) |
| 551 | Sensitive Troponins – Which Suits Better for Hemodialysis Patients? Associated Factors and Prediction of Mortality | 2.5 | 47 | Citations (PDF) |
| 552 | Markers of Plaque Instability in the Early Diagnosis and Risk Stratification of Acute Myocardial Infarction | 1.1 | 51 | Citations (PDF) |
| 553 | Midregional Pro–A-Type Natriuretic Peptide for Diagnosis and Prognosis in Patients With Suspected Acute Myocardial Infarction | 1.9 | 11 | Citations (PDF) |
| 554 | Increasing B-type natriuretic peptide levels predict mortality in unselected haemodialysis patients | 8.2 | 21 | Citations (PDF) |
| 555 | Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure | 6.9 | 85 | Citations (PDF) |
| 556 | Value of arterial blood gas analysis in patients with acute dyspnea: an observational study | 6.9 | 38 | Citations (PDF) |
| 557 | “Universal Definition” Methodology and Conclusions Are a Concern | 2.6 | 0 | Citations (PDF) |
| 558 | Midregion Prohormone Adrenomedullin and Prognosis in Patients Presenting With Acute Dyspnea | 2.6 | 118 | Citations (PDF) |
| 559 | Acoustic cardiography S3 detection use in problematic subgroups and B-type natriuretic peptide “gray zone”: secondary results from the Heart failure and Audicor technology for Rapid Diagnosis and Initial Treatment Multinational Investigation | 1.6 | 14 | Citations (PDF) |
| 560 | Use of Neutrophil Count in Early Diagnosis and Risk Stratification of AMI | 2.1 | 34 | Citations (PDF) |
| 561 | B-type Natriuretic Peptide in the Early Diagnosis and Risk Stratification of Acute Chest Pain | 2.1 | 26 | Citations (PDF) |
| 562 | N-terminal Pro B-type Natriuretic Peptide in the Early Evaluation of Suspected Acute Myocardial Infarction | 2.1 | 29 | Citations (PDF) |
| 563 | The Reply | 2.1 | 0 | Citations (PDF) |
| 564 | Patients with Acute Coronary Syndrome and Normal High-sensitivity Troponin | 2.1 | 21 | Citations (PDF) |
| 565 | Systolic blood pressure at Emergency Department presentation and 1-year mortality in acute chest pain patients | 2.6 | 4 | Citations (PDF) |
| 566 | Determinants of absolute and relative exercise-induced changes in B-type natriuretic peptides | 2.2 | 10 | Citations (PDF) |
| 567 | High-sensitive Troponin, B-type natriuretic peptide and coronary angiogram findings in patients with non ST-segment elevation acute coronary syndrome | 2.2 | 2 | Citations (PDF) |
| 568 | Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays | 2.2 | 245 | Citations (PDF) |
| 569 | Utile or futile: biomarkers in the ICU | 6.9 | 5 | Citations (PDF) |
| 570 | Endogenous stress response in Tako-Tsubo cardiomyopathy and acute myocardial infarction | 3.2 | 18 | Citations (PDF) |
| 571 | Disparity of Care in the Acute Care of Patients With Heart Failure | 1.8 | 3 | Citations (PDF) |
| 572 | Short‐term Mortality Risk in Emergency Department Acute Heart Failure | 1.8 | 64 | Citations (PDF) |
| 573 | Effect and Clinical Prediction of Worsening Renal Function in Acute Decompensated Heart Failure | 1.9 | 49 | Citations (PDF) |
| 574 | Use of B‐type natriuretic peptide in the management of hypoxaemic respiratory failure | 8.2 | 13 | Citations (PDF) |
| 575 | Prognostic utility of plasma neutrophil gelatinase‐associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B‐type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial | 8.2 | 204 | Citations (PDF) |
| 576 | The GRACE score's performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptideHeart, 2011, 97, 1479-1483 | 2.8 | 62 | Citations (PDF) |
| 577 | Central venous pressure and impaired renal function in patients with acute heart failure | 8.2 | 95 | Citations (PDF) |
| 578 | Utility of Absolute and Relative Changes in Cardiac Troponin Concentrations in the Early Diagnosis of Acute Myocardial Infarction | 19.4 | 397 | Citations (PDF) |
| 579 | Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction | 2.2 | 46 | Citations (PDF) |
| 580 | Increased 90-Day Mortality in Patients With Acute Heart Failure With Elevated Copeptin | 4.8 | 154 | Citations (PDF) |
| 581 | Incremental Value of High-Sensitivity Cardiac Troponin T for Risk Prediction in Patients with Suspected Acute Myocardial Infarction | 1.1 | 42 | Citations (PDF) |
| 582 | Addressing unmet clinical needs in the early diagnosis of sepsis | 1.5 | 10 | Citations (PDF) |
| 583 | Risk stratification for 1-year mortality in acute heart failure: classification and regression tree analysis | 1.5 | 8 | Citations (PDF) |
| 584 | Central venous pressure at emergency room presentation predicts cardiac rehospitalization in patients with decompensated heart failure | 8.2 | 25 | Citations (PDF) |
| 585 | B-type natriuretic peptide in patients undergoing orthopaedic surgery: a prospective cohort study | 5.6 | 17 | Citations (PDF) |
| 586 | Comment on “High-Sensitivity Cardiac Troponin: Hype, Help, and Reality” | 1.1 | 1 | Citations (PDF) |
| 587 | Copeptin Response to Clinical Maximal Exercise Tests | 1.1 | 17 | Citations (PDF) |
| 588 | Use of Myeloperoxidase for Risk Stratification in Acute Heart Failure | 1.1 | 101 | Citations (PDF) |
| 589 | Natriuretic peptide‐guided management by the general practitioner: how to interpret the SIGNAL | 8.2 | 1 | Citations (PDF) |
| 590 | Clinical Application of Sensitive Cardiac Troponin Assays: Potential and Limitations | 1.6 | 12 | Citations (PDF) |
| 591 | Mid-Region Pro-Hormone Markers for Diagnosis and Prognosis in Acute Dyspnea | 2.6 | 455 | Citations (PDF) |
| 592 | Effect of oral beta-blocker on short and long-term mortality in patients with acute respiratory failure: results from the BASEL-II-ICU study | 6.9 | 38 | Citations (PDF) |
| 593 | Copeptin and risk stratification in patients with acute dyspnea | 6.9 | 46 | Citations (PDF) |
| 594 | Impact of history of heart failure on diagnostic and prognostic value of BNP: Results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) Study | 2.2 | 22 | Citations (PDF) |
| 595 | Midregional pro-A-type natriuretic peptide for the evaluation of exercise intolerance | 2.2 | 2 | Citations (PDF) |
| 596 | Recommendations for the use of cardiac troponin measurement in acute cardiac care | 2.2 | 522 | Citations (PDF) |
| 597 | Novelties in the early management of acute heart failure syndromes | 1.5 | 4 | Citations (PDF) |
| 598 | Relation of N-Terminal Pro-B-Type Natriuretic Peptide to Symptoms, Severity, and Left Ventricular Remodeling in Patients With Organic Mitral Regurgitation | 1.9 | 29 | Citations (PDF) |
| 599 | S3 Detection as a Diagnostic and Prognostic Aid in Emergency Department Patients With Acute Dyspnea | 0.7 | 61 | Citations (PDF) |
| 600 | Midregional pro-Adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study | 6.9 | 46 | Citations (PDF) |
| 601 | Use of copeptin in the detection of myocardial ischemia | 1.2 | 40 | Citations (PDF) |
| 602 | Natriuretic peptides for the prediction of severely impaired peak VO2 in patients with lung disease | 2.8 | 8 | Citations (PDF) |
| 603 | Use of changes in B-type natriuretic peptides to detect ischemia in selected patients | 2.2 | 8 | Citations (PDF) |
| 604 | The use of B-type natriuretic peptide in the management of patients with atrial fibrillation and dyspnea | 2.2 | 9 | Citations (PDF) |
| 605 | B-type natriuretic peptide–guided management and outcome in patients with obesity and dyspnea—Results from the BASEL study | 2.9 | 16 | Citations (PDF) |
| 606 | B-Type Natriuretic Peptides for the Evaluation of Exercise Intolerance | 2.1 | 11 | Citations (PDF) |
| 607 | Diagnostic and Prognostic Value of Uric Acid in Patients with Acute Dyspnea | 2.1 | 10 | Citations (PDF) |
| 608 | Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays | 25.5 | 1,443 | Citations (PDF) |
| 609 | B-Type Natriuretic Peptide in Children | 2.6 | 8 | Citations (PDF) |
| 610 | Incremental Value of Copeptin for Rapid Rule Out of Acute Myocardial Infarction | 2.6 | 369 | Citations (PDF) |
| 611 | Cardiovascular biomarkers in the ICU | 3.6 | 16 | Citations (PDF) |
| 612 | Acute respiratory failure: back to the roots! | 5.2 | 2 | Citations (PDF) |
| 613 | Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia | 2.7 | 43 | Citations (PDF) |
| 614 | Accuracy of chest radiographs in the emergency diagnosis of heart failure | 3.8 | 22 | Citations (PDF) |
| 615 | Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting as Primary Revascularization in Patients With Acute Coronary Syndrome | 1.9 | 12 | Citations (PDF) |
| 616 | B‐Type Natriuretic Peptide: Application in the Community | 2.6 | 2 | Citations (PDF) |
| 617 | Cost‐Effectiveness of B‐Type Natriuretic Peptide Testing | 2.6 | 10 | Citations (PDF) |
| 618 | Natriuretic Peptides in Acute Coronary Syndromes: Prognostic Value and Clinical Implications | 2.6 | 11 | Citations (PDF) |
| 619 | Cost‐Effectiveness of B‐Type Natriuretic Peptide Testing | 2.6 | 4 | Citations (PDF) |
| 620 | The Use of B‐Type Natriuretic Peptides in the Intensive Care Unit | 2.6 | 3 | Citations (PDF) |
| 621 | Multimarker strategy for risk prediction in patients presenting with acute dyspnea to the emergency department | 2.2 | 20 | Citations (PDF) |
| 622 | Use of B-type natriuretic peptide outside of the emergency department | 2.2 | 34 | Citations (PDF) |
| 623 | New Definition of Myocardial Infarction: Impact on Long-term Mortality | 2.1 | 40 | Citations (PDF) |
| 624 | Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET | 2.2 | 91 | Citations (PDF) |
| 625 | CD11b+ Monocytes Abrogate Th17 CD4+ T Cell-Mediated Experimental Autoimmune Myocarditis | 0.6 | 126 | Citations (PDF) |
| 626 | Use of B-Type Natriuretic Peptide in the Risk Stratification of Acute Exacerbations of COPDChest, 2008, 133, 1088-1094 | 0.5 | 103 | Citations (PDF) |
| 627 | Risk stratification in acute decompensated heart failure: the role of cardiac troponin | 0.1 | 7 | Citations (PDF) |
| 628 | Acute and Long-term Outcome of Endovascular Therapy for Aortoiliac Occlusive Lesions Stratified According to the TASC Classification:<b>A Single-Center Experience</b> | 1.7 | 65 | Citations (PDF) |
| 629 | State of the art: Using natriuretic peptide levels in clinical practice | 8.2 | 647 | Citations (PDF) |
| 630 | Plasma Pro-Adrenomedullin But Not Plasma Pro-Endothelin Predicts Survival in Exacerbations of COPDChest, 2008, 134, 263-272 | 0.5 | 92 | Citations (PDF) |
| 631 | The use of natriuretic peptides in the intensive care unit | 3.6 | 2 | Citations (PDF) |
| 632 | Comparison of the Diagnostic Accuracy of BNP and NT-proBNP in Acute and Chronic Heart Failure | 1.1 | 4 | Citations (PDF) |
| 633 | Medical and Economic Long-term Effects of B-Type Natriuretic Peptide Testing in Patients with Acute Dyspnea | 1.1 | 45 | Citations (PDF) |
| 634 | B-type natriuretic peptide levels predict event-free survival in patients with implantable cardioverter defibrillators | 8.2 | 10 | Citations (PDF) |
| 635 | The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction | 2.2 | 108 | Citations (PDF) |
| 636 | Free and Total Cortisol Levels as Predictors of Severity and Outcome in Community-acquired Pneumonia | 9.7 | 108 | Citations (PDF) |
| 637 | Copeptin, C-Reactive Protein, and Procalcitonin as Prognostic Biomarkers in Acute Exacerbation of COPDChest, 2007, 131, 1058-1067 | 0.5 | 221 | Citations (PDF) |
| 638 | QRS and QTc interval prolongation in the prediction of long-term mortality of patients with acute destabilised heart failureHeart, 2007, 93, 1093-1097 | 2.8 | 44 | Citations (PDF) |
| 639 | The use of B-type natriuretic peptides in the intensive care unit* | 0.6 | 4 | Citations (PDF) |
| 640 | Antibiotic Treatment of Exacerbations of COPD | 0.5 | 479 | Citations (PDF) |
| 641 | Brain natriuretic peptide for prediction of Cheyne-Stokes respiration in heart failure patients | 2.2 | 35 | Citations (PDF) |
| 642 | The use of B-type natriuretic peptides in the detection of myocardial ischemia in settings with rapid access to coronary angiography | 2.2 | 11 | Citations (PDF) |
| 643 | Neurohormonal activation and left ventricular ejection fraction in patients with suspected myocardial ischemia | 2.2 | 8 | Citations (PDF) |
| 644 | The Use of B-Type Natriuretic Peptides in Coronary Artery Disease | 2.6 | 6 | Citations (PDF) |
| 645 | B-Type Natriuretic Peptides and the General Practitioner⁎⁎Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology. | 2.6 | 2 | Citations (PDF) |
| 646 | Treatment of reoccurring instent restenosis following reintervention after stent‐supported renal artery angioplasty | 1.8 | 46 | Citations (PDF) |
| 647 | Treatment of instent restenosis following stent‐supported renal artery angioplasty | 1.8 | 29 | Citations (PDF) |
| 648 | Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia | 2.7 | 317 | Citations (PDF) |
| 649 | Regression of Left Ventricular Hypertrophy Following Stenting of Renal Artery Stenosis | 1.7 | 17 | Citations (PDF) |
| 650 | Two-year Results After Directional Atherectomy of Infrapopliteal Arteries With the Silverhawk Device | 1.7 | 48 | Citations (PDF) |
| 651 | Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia | 9.7 | 787 | Citations (PDF) |
| 652 | Gender-Specific Risk Stratification With B-Type Natriuretic Peptide Levels in Patients With AcuteDyspnea | 2.6 | 53 | Citations (PDF) |
| 653 | Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents | 2.6 | 1,156 | Citations (PDF) |
| 654 | Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397] | 6.9 | 200 | Citations (PDF) |
| 655 | Use of B-type natriuretic peptide in the management of acute dyspnea in patients with pulmonary disease | 2.9 | 57 | Citations (PDF) |
| 656 | Use of B-type natriuretic peptide in the detection of myocardial ischemia | 2.9 | 71 | Citations (PDF) |
| 657 | Inflammation and long-term mortality in acute congestive heart failure | 2.9 | 112 | Citations (PDF) |
| 658 | The impact of platelet count on mortality in unstable angina/non–ST-segment elevation myocardial infarction | 2.9 | 45 | Citations (PDF) |
| 659 | Hypertension is an independent risk factor for contrast nephropathy after percutaneous coronary intervention | 2.2 | 20 | Citations (PDF) |
| 660 | Cost-effectiveness of B-Type Natriuretic Peptide Testing in Patients With Acute Dyspnea | 8.9 | 105 | Citations (PDF) |
| 661 | Incidence, risk factors, and outcome of aspiration pneumonitis in ICU overdose patients | 5.2 | 47 | Citations (PDF) |
| 662 | B-type natriuretic peptide for acute dyspnea in patients with kidney disease: Insights from a randomized comparison | 5.6 | 63 | Citations (PDF) |
| 663 | Impact of Carbon Coating on the Restenosis Rate After Stenting of Atherosclerotic Renal Artery Stenosis | 1.7 | 23 | Citations (PDF) |
| 664 | Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia | 2.1 | 50 | Citations (PDF) |
| 665 | <b>Stent-Supported Angioplasty of Severe Atherosclerotic Renal Artery Stenosis Preserves Renal Function and Improves Blood Pressure Control:</b>Long-term Results From a Prospective Registry of 456 Lesions | 1.7 | 81 | Citations (PDF) |
| 666 | Percutaneous Peripheral Atherectomy of Femoropopliteal Stenoses Using a New-Generation Device:Six-Month Results From a Single-Center Experience | 1.7 | 96 | Citations (PDF) |
| 667 | Procalcitonin and the Early Diagnosis of Infective Endocarditis | 19.4 | 66 | Citations (PDF) |
| 668 | Use of B-type natriuretic peptide for the management of women with dyspnea | 1.9 | 39 | Citations (PDF) |
| 669 | Human factors affect the quality of cardiopulmonary resuscitation in simulated cardiac arrests | 3.0 | 286 | Citations (PDF) |
| 670 | Midterm Results after Atherectomy-assisted Angioplasty of Below-Knee Arteries with Use of the Silverhawk Device | 0.7 | 66 | Citations (PDF) |
| 671 | Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea | 25.5 | 846 | Citations (PDF) |
| 672 | Prognostic value of the admission electrocardiogram in patients with unstable angina/non–ST-segment elevation myocardial infarction treated with very early revascularization | 2.1 | 33 | Citations (PDF) |
| 673 | Prognostic value of quantitative troponin T measurements in unstable angina/non-ST-segment elevation acute myocardial infarction treated early and predominantly with percutaneous coronary intervention | 2.1 | 29 | Citations (PDF) |
| 674 | Cost-effectiveness of intracoronary ultrasound for percutaneous coronary interventions | 1.9 | 29 | Citations (PDF) |
| 675 | Stent angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis | 1.8 | 96 | Citations (PDF) |
| 676 | Gold coating and restenosis after primary stenting of ostial renal artery stenosis | 1.8 | 40 | Citations (PDF) |
| 677 | A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents | 2.6 | 60 | Citations (PDF) |
| 678 | Clopidogrel versus ticlopidine after the placement of coronary artery stents: Reply | 2.6 | 0 | Citations (PDF) |
| 679 | Predictors of Improved Renal Function After Percutaneous Stent-Supported Angioplasty of Severe Atherosclerotic Ostial Renal Artery Stenosis | 19.4 | 203 | Citations (PDF) |
| 680 | Early Experience With a Rotational Thrombectomy Device for Treatment of Acute and Subacute Infra-aortic Arterial Occlusions | 1.7 | 16 | Citations (PDF) |
| 681 | Survival After Stenting of Severe Atherosclerotic Ostial Renal Artery Stenoses | 1.7 | 19 | Citations (PDF) |
| 682 | Technological Advances in the Design of Catheters and Devices Used in Renal Artery Interventions: Impact on Complications | 1.7 | 19 | Citations (PDF) |
| 683 | Prevention of Contrast Media–Associated Nephropathy | 8.9 | 667 | Citations (PDF) |
| 684 | Inflammation and Long-Term Mortality After Non–ST Elevation Acute Coronary Syndrome Treated With a Very Early Invasive Strategy in 1042 Consecutive Patients | 19.4 | 208 | Citations (PDF) |
| 685 | Gadodiamide as an Alternative Contrast Agent During Angioplasty in Patients With Contraindications to Iodinated Media | 1.7 | 24 | Citations (PDF) |
| 686 | Women do have an improved long-term outcome after non–ST-elevation acute coronary syndromes treated very early and predominantly with percutaneous coronary intervention | 2.6 | 85 | Citations (PDF) |
| 687 | Late aortic dislocation of a stent following stent angioplasty for ostial renal artery stenosis | 1.8 | 2 | Citations (PDF) |
| 688 | Single device approach to ultrasound-guided percutaneous transluminal coronary angioplasty and stenting: Initial experience with a combined intracoronary ultrasound/variable diameter balloon 1997, 40, 393-399 | | 3 | Citations (PDF) |
| 689 | Impaired production of tumor necrosis factor in breast cancer | 4.4 | 23 | Citations (PDF) |
| 690 | The Prevalence and Prognostic Significance of Near Syncope and Syncope | 0.2 | 15 | Citations (PDF) |
| 691 | High-sensitive cardiac troponin: friend or foe? | 1.5 | 22 | Citations (PDF) |
| 692 | Perioperative myocardial infarction/injury after noncardiac surgery | 1.5 | 12 | Citations (PDF) |
| 693 | Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling study | 0.2 | 26 | Citations (PDF) |
